Karen Krasney sold CAPR stock

Karen Krasney, EVP, General Counsel of Capricor Therapeutics, Inc. (CAPR), sold 24,100 shares of CAPR stock, per an SEC Form 4 filed Jun 30, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 25, 2026, 5 days before it was made public.

CAPR has moved -63.1% since the trade date, from $30.40 to $11.22 (Nov 11, 2026 close).